AIRLINK 189.64 Decreased By ▼ -7.01 (-3.56%)
BOP 10.09 Decreased By ▼ -0.05 (-0.49%)
CNERGY 6.68 Decreased By ▼ -0.01 (-0.15%)
FCCL 34.14 Increased By ▲ 1.12 (3.39%)
FFL 17.09 Increased By ▲ 0.44 (2.64%)
FLYNG 23.83 Increased By ▲ 1.38 (6.15%)
HUBC 126.05 Decreased By ▼ -1.24 (-0.97%)
HUMNL 13.79 Decreased By ▼ -0.11 (-0.79%)
KEL 4.77 Increased By ▲ 0.01 (0.21%)
KOSM 6.58 Increased By ▲ 0.21 (3.3%)
MLCF 43.28 Increased By ▲ 1.06 (2.51%)
OGDC 224.96 Increased By ▲ 11.93 (5.6%)
PACE 7.38 Increased By ▲ 0.37 (5.28%)
PAEL 41.74 Increased By ▲ 0.87 (2.13%)
PIAHCLA 17.19 Increased By ▲ 0.37 (2.2%)
PIBTL 8.41 Increased By ▲ 0.12 (1.45%)
POWER 9.05 Increased By ▲ 0.23 (2.61%)
PPL 193.09 Increased By ▲ 9.52 (5.19%)
PRL 37.34 Decreased By ▼ -0.93 (-2.43%)
PTC 24.02 Decreased By ▼ -0.05 (-0.21%)
SEARL 94.54 Decreased By ▼ -0.57 (-0.6%)
SILK 0.99 Decreased By ▼ -0.01 (-1%)
SSGC 39.93 Decreased By ▼ -0.38 (-0.94%)
SYM 17.77 Decreased By ▼ -0.44 (-2.42%)
TELE 8.66 Decreased By ▼ -0.07 (-0.8%)
TPLP 12.39 Increased By ▲ 0.18 (1.47%)
TRG 62.65 Decreased By ▼ -1.71 (-2.66%)
WAVESAPP 10.28 Decreased By ▼ -0.16 (-1.53%)
WTL 1.75 Decreased By ▼ -0.04 (-2.23%)
YOUW 3.97 Decreased By ▼ -0.03 (-0.75%)
BR100 11,814 Increased By 90.4 (0.77%)
BR30 36,234 Increased By 874.6 (2.47%)
KSE100 113,247 Increased By 609 (0.54%)
KSE30 35,712 Increased By 253.6 (0.72%)

The shortage of life-saving drugs, antibiotics and other medicines used to treat flu, fever, cold and coughs persist in the market with significant increase in prices, revealed a survey conducted by Business Recorder. Traders in different markets of the twin cities of Rawalpindi and Islamabad said that with the advent of winter, another wave of medicine shortages with increase in prices is fast approaching.
The main reason for the shortage was attributed to increase in input cost and ephedrine quota allotment scam. Chairman Pakistan Pharmaceutical Manufacturers' Association (PPMA) Mohammad Asad told Business Recorder that many manufacturers deliberately hesitate to lift the allotted ephedrine quota as a result of the ephedrine scam, which brought down the production of many lifesaving and other drugs, creating a supply-demand gap as well as increasing their prices. Giving another reason for the increase in medicine prices, Asad said that some pharmaceutical companies have taken stay orders and the matter is sub- judice in the court.
Sources in the pharmaceutical industry said that the ephedrine quota, which was usually allocated in January has this year been allocated in August and September hence the production of drugs has been delayed. The pharmaceutical companies significantly increased the prices of most lifesaving drugs during the last few months without government consent, besides creating a shortage, with antibiotics and painkillers not available in the market.
Soon after the ephedrine scandal, markets witnessed shortage of medicines like thyroxin tablet, vancocin injection, cardarone, inderal, benadryl, xanax, lexotanil, ativan, betnesol N-drops, polyfax, hydryllin DM and arinac. Similarly lifesaving drugs which are short in the markets include aminessn used for bones/spinal cord, cofcol syrup used for cough, dormicum tablets used for sleeping, loftyl for the treatment of epilepsy, corex D syrup for the treatment of cough loprin tablet 75mg, arinac tablet and syrup used as anti-allergic medicine, mucaine syrup, singluair used by asthmatic patients and klaracid, an important antibiotic medicine.
Patients in the twin cities of Rawalpindi/Islamabad are running from post to pillar for these medicines. The prices of life saving drugs and other essential medicines registered a substantial increase during the last few months: Disprin was previously available at Rs 7, is now available at Rs 10. Similarly, the price of peditral ORS increased from Rs 9 to Rs 27, hydraline syrup from Rs 30 to Rs 59, pulmonol syrup from Rs 39 to Rs 65, vermox syrup from Rs 30 to Rs 40, panadol tablet from Rs 7 to Rs 9, corex D syrup from Rs 28 to Rs 40 and loprin tablet 75mg from Rs 30 to Rs 33.

Copyright Business Recorder, 2012

Comments

Comments are closed.